المؤلفون: Nadeu, Ferran, Syrykh, Charlotte, Pons-Brun, Berta, Russiñol, Núria, Playa-Albinyana, Heribert, Baumann, Tycho Stephan, Duran-Ferrer, Martí, Kulis, Marta, Carbó-Meix, Anna, Mozas, Pablo, Alcoceba, Miguel, González, Marcos, Navarro-Bailón, Almudena, Colado, Enrique, Payer, Ángel, Aymerich, Marta, Terol, María José, Lu, Junyan, Knisbacher, Binyamin Asher, Hahn, Cynthia K, Ruiz-Gaspà, Sílvia, Enjuanes, Anna, Wu, Catherine J, Getz, Gad, Zenz, Thorsten, López-Guillermo, Armando, Martin-Subero, Jose I, Colomer, Dolors, Delgado, Julio, Campo, Elías

المصدر: Nadeu, Ferran; Syrykh, Charlotte; Pons-Brun, Berta; Russiñol, Núria; Playa-Albinyana, Heribert; Baumann, Tycho Stephan; Duran-Ferrer, Martí; Kulis, Marta; Carbó-Meix, Anna; Mozas, Pablo; Alcoceba, Miguel; González, Marcos; Navarro-Bailón, Almudena; Colado, Enrique; Payer, Ángel; Aymerich, Marta; Terol, María José; Lu, Junyan; Knisbacher, Binyamin Asher; Hahn, Cynthia K; Ruiz-Gaspà, Sílvia; Enjuanes, Anna; Wu, Catherine J; Getz, Gad; Zenz, Thorsten; López-Guillermo, Armando; Martin-Subero, Jose I; Colomer, Dolors; Delgado, Julio; Campo, Elías (2023). IGLV3-21$^{R110}$ mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia. Blood Advances, 7(23):7384-7391.

مصطلحات موضوعية: Clinic for Oncology and Hematology, 610 Medicine & health

وصف الملف: application/pdf

Relation: https://www.zora.uzh.ch/id/eprint/239059/1/ZORA_239059.pdf; info:pmid/37505099; urn:issn:2473-9529

الاتاحة: https://www.zora.uzh.ch/id/eprint/239059/
https://www.zora.uzh.ch/id/eprint/239059/1/ZORA_239059.pdf
https://doi.org/10.1182/bloodadvances.2023010132

المؤلفون: Nadeu, Ferran; https://orcid.org/0000-0003-2910-9440, Syrykh, Charlotte, Pons-Brun, Berta, Russiñol, Núria, Playa-Albinyana, Heribert; https://orcid.org/0000-0002-3447-3848, Baumann, Tycho Stephan, Duran-Ferrer, Martí; https://orcid.org/0000-0003-1666-5819, Kulis, Marta; https://orcid.org/0000-0001-8104-9620, Carbó-Meix, Anna, Mozas, Pablo; https://orcid.org/0000-0001-9528-4971, Alcoceba, Miguel, González, Marcos; https://orcid.org/0000-0001-6637-1072, Navarro-Bailón, Almudena; https://orcid.org/0000-0002-7972-5666, Colado, Enrique, Payer, Ángel, Aymerich, Marta, Terol, María José, Lu, Junyan; https://orcid.org/0000-0002-9211-0746, Knisbacher, Binyamin Asher; https://orcid.org/0000-0002-4962-9956, Hahn, Cynthia K; https://orcid.org/0000-0001-8284-7261, Ruiz-Gaspà, Sílvia, Enjuanes, Anna, Wu, Catherine J; https://orcid.org/0000-0002-3348-5054, Getz, Gad, Zenz, Thorsten; https://orcid.org/0000-0001-7890-9845, López-Guillermo, Armando, Martin-Subero, Jose I; https://orcid.org/0000-0001-8809-5195, Colomer, Dolors, Delgado, Julio; https://orcid.org/0000-0002-5157-4376, Campo, Elías; https://orcid.org/0000-0001-9850-9793

المصدر: Nadeu, Ferran; Syrykh, Charlotte; Pons-Brun, Berta; Russiñol, Núria; Playa-Albinyana, Heribert; Baumann, Tycho Stephan; Duran-Ferrer, Martí; Kulis, Marta; Carbó-Meix, Anna; Mozas, Pablo; Alcoceba, Miguel; González, Marcos; Navarro-Bailón, Almudena; Colado, Enrique; Payer, Ángel; Aymerich, Marta; Terol, María José; Lu, Junyan; Knisbacher, Binyamin Asher; Hahn, Cynthia K; Ruiz-Gaspà, Sílvia; Enjuanes, Anna; Wu, Catherine J; Getz, Gad; Zenz, Thorsten; López-Guillermo, Armando; Martin-Subero, Jose I; Colomer, Dolors; Delgado, Julio; Campo, Elías (2023). IGLV3-21$^{R110}$ mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia. Blood Advances, 7(23):7384-7391.

مصطلحات الفهرس: Clinic for Oncology and Hematology, 610 Medicine & health, Journal Article, PeerReviewed, info:eu-repo/semantics/article, info:eu-repo/semantics/publishedVersion

URL: https://www.zora.uzh.ch/id/eprint/239059/
https://www.zora.uzh.ch/id/eprint/239059
10.1182/bloodadvances.2023010132